Gene: PCNX2
Official Full Name: pecanex 2provided by HGNC
Gene Summary: This gene contains coding mononucleotide repeats that are associated with tumors of high mcrosatellite instability (MSI-H). Defects in this gene are involved in the tumorigenesis of MSI-H colorectal carcinomas. [provided by RefSeq, Jun 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26276 | PCNX2 Knockout cell line (HeLa) | Human | PCNX2 | 1:3~1:6 | Negative | Online Inquiry |
KO26277 | PCNX2 Knockout cell line (HCT 116) | Human | PCNX2 | 1:2~1:4 | Negative | Online Inquiry |
KO26278 | PCNX2 Knockout cell line (HEK293) | Human | PCNX2 | 1:3~1:6 | Negative | Online Inquiry |
KO26279 | PCNX2 Knockout cell line (A549) | Human | PCNX2 | 1:3~1:4 | Negative | Online Inquiry |
PCNX2 Gene Knockout Cell Lines are a specialized biological product designed for researchers investigating the functional roles of the PCNX2 gene in various cellular processes. Gene knockout technology is a pivotal tool in molecular biology that involves the targeted inactivation of a specific gene, allowing for the assessment of its contributions to phenotype and cellular behavior. These cell lines have been meticulously engineered to contain a complete disruption of the PCNX2 gene, providing a unique platform for studying its implications in disease mechanisms, cell signaling, and various metabolic pathways.
The key function of PCNX2 Gene Knockout Cell Lines lies in their ability to facilitate loss-of-function studies, enabling researchers to observe the resultant phenotypic changes within cellular systems devoid of PCNX2 expression. By utilizing CRISPR/Cas9 or similar genome-editing technologies, the knockout cell lines ensure precise and efficient gene inactivation, allowing for the investigation of the downstream effects on cellular proliferation, differentiation, and response to external stimuli.
The scientific importance of these cell lines cannot be overstated. They represent invaluable tools in both basic and translational research settings, including cancer studies, neurological disorder investigations, and the exploration of regenerative medicine. These cell lines enable clinicians and researchers to unravel the complex biological functions of the PCNX2 gene, thereby paving the way for the development of novel therapeutic strategies.
One of the distinct advantages of our PCNX2 Gene Knockout Cell Lines is their rigorously validated performance and the comprehensive characterization data provided. This gives researchers confidence in reproducibility and reliability compared to other alternatives that may lack such extensive documentation. Additionally, our product offers a more efficient and ethical means of conducting genetic research than traditional gene alteration methods.
For researchers and clinicians who are aiming to delve into gene function and its implications in disease, the PCNX2 Gene Knockout Cell Lines offer unparalleled value. They streamline experimental workflows and enhance the potential for discovering new insights into health and disease.
Our company has a longstanding commitment to producing high-quality biological products, backed by extensive research and development. With a focus on precision and scientific excellence, we are dedicated to supporting the scientific community in advancing knowledge and therapeutics in biology and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.